Sophisticated Cloning, Fermentation, and Purification Technologies for an Enhanced Therapeutic Protein Production: A Review

The protein productions strategies are crucial towards the development of application based research and elucidating the novel purification strategies for industrial production. Currently, there are few innovative avenues are studies for cloning, upstream, and purification through efficient bioprocess development. Such strategies are beneficial for industries as well as proven to be vital for effectual therapeutic protein development. Though, these techniques are well documented, but, there is scope of addition to current knowledge with novel and new approaches and it will pave new avenues in production of recombinant microbial and non-microbial proteins including secondary metabolites. In this review, we have focussed on the recent development in clone selection, various modern fermentation and purification technologies and future directions in these emerging areas. Moreover, we have also highlighted notable perspectives and challenges involved in the bioengineering of such proteins, including quality by design, gene editing and pioneering ideas. The biopharmaceutical industries continue to shift towards more flexible, automated platforms and economical product development, which in turn can help in developing the cost effective processes and affordable drug development for a large community.

• Publication year

  2017

• Venue

  Frontiers in Pharmacology

• Publication date

  2017-07-04

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.3389/fphar.2017.00419PMID 28725194PMCID 5495827
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bioprocess Engineering

  2019cited by this paper
• Enhanced integration of large DNA into E. coli chromosome by CRISPR/Cas9

  2017influential reference
• Microbial platform technology for recombinant antibody fragment production: A review

  2017influential reference
• Gene editing for cell engineering: trends and applications

  2017influential reference
• Cellular engineering for therapeutic protein production: product quality, host modification, and process improvement

  2017influential reference
• Advanced technologies for improved expression of recombinant proteins in bacteria: perspectives and applications

  2016cited by this paper
• A Single-use Strategy to Enable Manufacturing of Affordable Biologics

  2016cited by this paper
• Continuous bind‐and‐elute protein A capture chromatography: Optimization under process scale column constraints and comparison to batch operation

  2016cited by this paper
• Advances in therapeutic CRISPR/Cas9 genome editing.

  2016cited by this paper
• Fresh from the biotech pipeline—2015

  2016cited by this paper
• Production of natural products through metabolic engineering of Saccharomyces cerevisiae.

  2015cited by this paper
• Engineering protein folding and translocation improves heterologous protein secretion in Saccharomyces cerevisiae

  2015cited by this paper
• Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection

  2015influential reference
• One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment.

  2015cited by this paper
• Overview of Microbial Therapeutic Enzymes

  2015cited by this paper
• Detoxifying Escherichia coli for endotoxin-free production of recombinant proteins

  2015cited by this paper
• Twin-column CaptureSMB: a novel cyclic process for protein A affinity chromatography.

  2015influential reference
• Efficient expression of full-length antibodies in the cytoplasm of engineered bacteria

  2015cited by this paper
• Developing the biofacility of the future based on continuous processing and single-use technology.

  2015cited by this paper
• Development of a fed-batch process for a recombinant Pichia pastoris Δoch1 strain expressing a plant peroxidase

  2015cited by this paper
• A folded and immunogenic IgE-hyporeactive variant of the major allergen Phl p 1 produced in Escherichia coli

  2015cited by this paper
• Complete clarification solution for processing high density cell culture harvests

  2015cited by this paper
• Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process

  2015cited by this paper
• Efficient Engineering and Production Concepts for Products in Regulated Environments – Dream or Nightmare?

  2014cited by this paper
• Over-expression of secreted proteins from mammalian cell lines

  2014cited by this paper
• Harmonization and characterization of different single‐use bioreactors adopting a new sparger design

  2014cited by this paper
• Corrigendum: Bats host major mammalian paramyxoviruses

  2014cited by this paper
• Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production

  2014cited by this paper
• Impact of protein uptake and degradation on recombinant protein secretion in yeast

  2014cited by this paper
• Paradigm shift for vaccine manufacturing facilities: The next generation of flexible, modular facilities

  2014cited by this paper
• Design of synthetic yeast promoters via tuning of nucleosome architecture

  2014cited by this paper
• Surface wave dynamics in orbital shaken cylindrical containers

  2014cited by this paper
• Microbials for the production of monoclonal antibodies and antibody fragments

  2014cited by this paper
• Small-scale expression of proteins in E. coli.

  2014cited by this paper
• Single‐use technologies in biopharmaceutical manufacturing: A 10‐year review of trends and the future

  2014cited by this paper
• Purification of an amide hydrolase DamH from Delftia sp. T3-6 and its gene cloning, expression, and biochemical characterization

  2014cited by this paper
• Analytical QbD: Development of a native gel electrophoresis method for measurement of monoclonal antibody aggregates

  2014cited by this paper
• Characterization, cloning and functional expression of novel xylanase from Thermomyces lanuginosus SS-8 isolated from self-heating plant wreckage material

  2013cited by this paper
• Periplasmic production via the pET expression system of soluble, bioactive human growth hormone.

  2013cited by this paper
• Preparative Purification of Recombinant Proteins: Current Status and Future Trends

  2013cited by this paper
• Genetic manipulation of longevity-related genes as a tool to regulate yeast life span and metabolite production during winemaking

  2013cited by this paper
• Bioengineering Parameters for Single‐Use Bioreactors: Overview and Evaluation of Suitable Methods

  2013cited by this paper
• Refolding of biotech therapeutic proteins expressed in bacteria: review

  2013cited by this paper
• Development of recombinant Chinese hamster ovary cell lines for therapeutic protein production

  2013cited by this paper
• Cell culture processes for biologics manufacturing: recent developments and trends

  2013cited by this paper
• Harnessing Candida tenuis and Pichia stipitis in whole‐cell bioreductions of o‐chloroacetophenone: Stereoselectivity, cell activity, in situ substrate supply and product removal

  2013cited by this paper
• Optimizing heterologous protein production in the periplasm of E. coli by regulating gene expression levels

  2013cited by this paper
• Single-use disposable technologies for biopharmaceutical manufacturing.

  2013influential reference
• Therapeutic antibodies: market considerations, disease targets and bioprocessing.

  2013cited by this paper
• Recent advances in technology supporting biopharmaceutical production from mammalian cells

  2012cited by this paper
• A Combined System for Engineering Glycosylation Efficiency and Glycan Structure in Saccharomyces cerevisiae

  2012cited by this paper
• Efficient, Flexible Facilities for the 21st Century

  2012cited by this paper
• Critical Factors Affecting the Success of Cloning, Expression, and Mass Production of Enzymes by Recombinant E. coli

  2012cited by this paper
• Membrane Technology in Bioprocess Science

  2012influential reference
• Integrated continuous production of recombinant therapeutic proteins

  2012cited by this paper
• Technology trends in antibody purification.

  2012cited by this paper
• Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements

  2012influential reference
• Quantitative impurity analysis of monoclonal antibody size heterogeneity by CE‐LIF: Example of development and validation through a quality‐by‐design framework

  2012cited by this paper
• SHuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulfide bonded proteins in its cytoplasm

  2012cited by this paper
• Mammalian cell protein expression for biopharmaceutical production.

  2012cited by this paper
• Host cell protein adsorption characteristics during protein a chromatography

  2012cited by this paper
• Membrane engineering in process intensificationAn overview

  2011cited by this paper
• Manufacturing recombinant proteins in kg-ton quantities using animal cells in bioreactors.

  2011influential reference
• High-throughput process development for biopharmaceutical drug substances.

  2011cited by this paper
• Downstream bioprocessing: recent advances and future promise

  2011influential reference
• Advances in the production and downstream processing of antibodies.

  2011influential reference
• A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design.

  2011cited by this paper
• Refolding of proteins from inclusion bodies: rational design and recipes

  2011cited by this paper
• Guidelines to cell engineering for monoclonal antibody production.

  2010influential reference
• Defining process design space for monoclonal antibody cell culture

  2010cited by this paper
• Maximizing productivity of CHO cell‐based fed‐batch culture using chemically defined media conditions and typical manufacturing equipment

  2010cited by this paper
• Engineering of protein secretion in yeast: strategies and impact on protein production

  2010cited by this paper
• BAK and BAX deletion using zinc‐finger nucleases yields apoptosis‐resistant CHO cells

  2010cited by this paper
• Novel micro‐bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed‐batch CHO cultures

  2010cited by this paper
• Profiling of host cell proteins by two‐dimensional difference gel electrophoresis (2D‐DIGE): Implications for downstream process development

  2010cited by this paper
• Recent advances in large-scale production of monoclonal antibodies and related proteins.

  2010influential reference
• Production and single-step purification of Brugia malayi abundant larval transcript (ALT-2) using hydrophobic interaction chromatography

  2010cited by this paper
• Recovery and purification process development for monoclonal antibody production

  2010influential reference
• Production of Secretory and Extracellular N-Linked Glycoproteins in Escherichia coli

  2010cited by this paper
• Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns

  2010cited by this paper
• Cell culture processes for monoclonal antibody production

  2010influential reference
• Characterization of a Monoclonal Antibody Cell Culture Production Process Using a Quality by Design Approach

  2010cited by this paper
• How to Choose an Industrial Cation Exchanger for IgG Purification

  2010cited by this paper
• Single-Use Systems As Principal Components in Bioproduction

  2010cited by this paper
• Expression of Recombinant Genes in the Yeast Pichia pastoris

  2010cited by this paper
• Defining process design space for a hydrophobic interaction chromatography (HIC) purification step: Application of quality by design (QbD) principles

  2010cited by this paper
• Biotechnological strains of Komagataella (Pichia) pastoris are Komagataellaphaffii as determined from multigene sequence analysis

  2009cited by this paper
• A clone screening method using mRNA levels to determine specific productivity and product quality for monoclonal antibodies

  2009cited by this paper
• A strategic crossflow filtration methodology for the initial purification of promegapoietin from inclusion bodies.

  2009cited by this paper
• Expression and Purification of SAK-fused Human Interferon Alpha in Escherichia coli

  2009cited by this paper
• Industrialization of mAb production technology: The bioprocessing industry at a crossroads

  2009cited by this paper
• Expression systems for therapeutic glycoprotein production.

  2009cited by this paper
• Roadmap for implementation of quality by design (QbD) for biotechnology products.

  2009cited by this paper
• Upstream processes in antibody production: evaluation of critical parameters.

  2008cited by this paper
• High Recovery Refolding of rhG‐CSF from Escherichia coli, Using Urea Gradient Size Exclusion Chromatography

  2008cited by this paper
• Defining Process Design Space for Biotech Products: Case Study of Pichia pastoris Fermentation

  2008cited by this paper
• Host cell protein clearance during protein a chromatography: Development of an improved column wash step

  2008cited by this paper
• Protein A chromatography for antibody purification.

  2007cited by this paper
• Process Development Considerations for Therapeutic Monoclonal Antibodies in Mammalian Cell Culture

  2007cited by this paper
• Recombinant protein therapeutics from CHO cells : 20 years and counting

  2007cited by this paper

• Unveiling microbial and microalgal chassis for therapeutic and diagnostic protein expression.

  2026cites this paper
• Plant production systems for recombinant immunotherapeutic proteins

  2025cites this paper
• A systematic approach for scalable purification of virus-like particles.

  2025cites this paper
• Structural deviations between native and precision fermentation-derived food proteins: techno-functionality and structure formation strategies

  2025cites this paper
• Precision Fermentation for the Next Generation of Food Ingredients: Opportunities and Challenges

  2025cites this paper
• Methanol‐Free Protein Expression in Komagataella phaffii With Magnetic or Non‐Magnetic Heating

  2025cites this paper
• Applications of recombinant proteins in cultured meat production

  2025cites this paper
• Antimicrobial Peptides: A Promising Solution to the Rising Threat of Antibiotic Resistance

  2024cites this paper
• Comprehensive insight into exploring the potential of microbial enzymes in cancer therapy: Progress, challenges, and opportunities: A review.

  2024cites this paper
• The use of proteins and peptides-based therapy in managing and preventing pathogenic viruses.

  2024cites this paper
• Saccharomyces cerevisiae as a Host for Chondroitin Production

  2024cites this paper
• Preparation of Bispecific IgY-scFvs Inhibition Adherences of Enterotoxigenic Escherichia coli (K88 and F18) to Porcine IPEC-J2 Cell

  2024cites this paper
• Therapeutic proteins: developments, progress, challenges, and future perspectives

  2024cites this paper
• Evolving Paradigms of Recombinant Protein Production in Pharmaceutical Industry: A Rigorous Review

  2024influential citation
• Purification and Quality Control of Recombinant Proteins Expressed in Mammalian Cells: A Practical Review.

  2024cites this paper
• Insect proteins – Production technologies, bio-functional, and food applications: A Perspective

  2024cites this paper
• Virtual screening and experimental analysis of caspase-7 inhibitors as candidates for extending the lifespan of CHO cells

  2024cites this paper
• Advanced delivery systems for peptide antibiotics.

  2023cites this paper
• Recent Developments in Bioprocessing of Recombinant Antibody Fragments

  2023cites this paper
• Pseudo-affinity capture of K. phaffii host cell proteins in flow-through mode: purification of protein therapeutics and proteomic study

  2023cites this paper
• Production of recombinant scorpion antivenoms in E. coli: current state and perspectives

  2023cites this paper
• Mini-Bioreactor Platform for Membrane Protein Production in Komagataella pastoris.

  2023cites this paper
• Current advances of Pichia pastoris as cell factories for production of recombinant proteins

  2022cites this paper
• Emerging trends and future perspectives on enzyme prospection with reference to food processing

  2022cites this paper
• Recombinant Protein Production and Purification of Insoluble Proteins.

  2022cites this paper
• Understanding Biosimilar Insulins - Development, Manufacturing, and Clinical Trials

  2022cites this paper
• Research Progress of Fermented Functional Foods and Protein Factory-Microbial Fermentation Technology

  2022cites this paper
• Cloning, Characterization, Expression Analysis, and Agglutination Studies of Novel Gene Encoding β-d-Galactose, N-Acetyl-d-Glucosamine and Lactose-Binding Lectin from Rice Bean (Vigna umbellata)

  2021cites this paper
• Protein drug production and formulation

  2021cites this paper
• Removal of N-terminal methionine of human interferon α-2b by co‐producing with Pyrococcus furiosus methionine aminopeptidase in Escherichia coli

  2021cites this paper
• Impact of glycerol feeding profiles on STEAP1 biosynthesis by Komagataella pastoris using a methanol-inducible promoter

  2021cites this paper
• Recombinant active Peptides and their Therapeutic functions.

  2021cites this paper
• Biotechnological Insights on the Expression and Production of Antimicrobial Peptides in Plants

  2021cites this paper
• Optimization of Multiparameters for Increased Yields of Cytochrome B5 in Bioreactors

  2021cites this paper
• Heterologous Protein Expression in Yeast and Molds

  2021cites this paper
• Selective Cell Propagation via Micropatterning of Thermal-activated Hydrogel

  2020cites this paper
• Effects of viral promoters, the Woodchuck hepatitis post-transcriptional regulatory element, and weakened antibiotic resistance markers on transgene expression in Chinese hamster ovary cells

  2020cites this paper
• Generation and testing of engineered multimeric Fabs of trastuzumab.

  2020cites this paper
• In vitro Impact of Yeast Expressed Hybrid Peptide CATH-2TP5 as a Prophylactic Measure Toward Sepsis and Inflammation

  2020cites this paper
• HEK293 Cells Overexpressing Nuclear Factor E2-Related Factor-2 Improve Expression of Recombinant Coagulation Factor VII

  2019cites this paper
• Production and Purification of Therapeutic Enzymes.

  2019cites this paper
• Differential effects of bioreactor process variables and purification on the human recombinant lysosomal enzyme β-glucuronidase produced from Chinese hamster ovary cells

  2019cites this paper
• Recent perspectives on the virulent factors and treatment options for multidrug-resistant Acinetobacter baumannii

  2019cites this paper
• Effectual Bioprocess Development for Protein Production

  2019cites this paper
• Application of the LEXSY Leishmania tarentolae system as a recombinant protein expression platform: A review

  2019cites this paper
• Biosimilars: An Approach to some Current Worldwide Regulation Frameworks.

  2019cites this paper
• Antimicrobial Peptides: Recent Insights on Biotechnological Interventions and Future Perspectives

  2019cites this paper
• Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development

  2019cites this paper
• The yeast stands alone: the future of protein biologic production.

  2018cites this paper
• Three-dimensional culture of chicken primordial germ cells in chemically defined media containing the functional polymer FP003

  2018cites this paper
• Update on biosimilars in inflammatory bowel disease: Position and recommendations in Mexico

  2018cites this paper
• Glycosylation control technologies for recombinant therapeutic proteins

  2018cites this paper
• Three-dimensional culture of chicken primordial germ cells (cPGCs) in defined media containing the functional polymer FP003

  2018cites this paper
• Futuristic biosensors for cardiac health care: an artificial intelligence approach

  2018cites this paper
• Efficient production of Trastuzumab Fab antibody fragments in Brevibacillus choshinensis expression system.

  2018cites this paper
• Update on biosimilars in inflammatory bowel disease: Position and recommendations in Mexico.

  2018cites this paper
• Progress in biopharmaceutical development

  2017cites this paper